Zepbound Access Update: Lilly Rolls Out Additional Vial Doses, New Savings for Self-pay Patients
Eli Lilly and Company is launching 7.5mg and 10mg Zepbound (tirzepatide) single-dose vials, available for $499 with the new Zepbound Self Pay Journey Program. Lilly also reduced the price of the 2.5mg and 5mg vials. These new offerings are available exclusively through LillyDirect Self Pay Pharmacy Solutions, which enables a transparent price by removing third-party supply chain […]